Skip to main content
argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
775.03
-8.71 (-1.11%)
At close: Apr 28, 2026, 4:00 PM EDT
771.50
-3.53 (-0.46%)
After-hours: Apr 28, 2026, 5:20 PM EDT

argenx SE Revenue

In the year 2025, argenx SE had annual revenue of $4.24B with 88.44% growth. argenx SE had revenue of $1.31B in the quarter ending December 31, 2025, with 73.04% growth.

Revenue (ttm)
$4.24B
Revenue Growth
+88.44%
P/S Ratio
11.44
Revenue / Employee
$2,274,004
Employees
1,863
Market Cap
48.47B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.24B1.99B88.44%
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Regeneron Pharmaceuticals 14.34B
Vertex Pharmaceuticals 12.00B
BeOne Medicines AG 5.34B
Incyte 5.14B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.37B
Royalty Pharma 2.38B
Moderna 1.94B
Revenue Rankings

ARGX News

More News